CClinicalTrials.gg
CompletedNCT03640104Updated Apr 28, 2021

Individualized Dietary Intervention in Breastfeeding Women: Body Weight and Vitamin A Stores

An interventional study of Intervention-Nutrition guidelines and Nutrition guidelines in Overweight and Obesity, Vitamin A Deficiency and Dietary Modification, sponsored by Universidad de Sonora. Completed at 1 site in Mexico. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-28.

Sponsored by Universidad de Sonora · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Breast milk is the best food during the first 6mo of life because it offers multiple benefits for the mother-infant pair. An inadequate maternal diet during pregnancy can lead to excess weight gain, leading to negative health consequences for the dyad. In Mexico, an excess of body weight coexists with micronutrient deficiencies (double burden of malnutrition). Low vitamin A concentration has been observed in northwest Mexico, which can affect the human milk composition and increase the risk of VAD in breastfed babies. An individualized dietary intervention in the lactating woman will reduce body weight and improve vitamin A status. The objective is to assess the effect of an individualized dietary intervention during 3 months postpartum on body composition and vitamin A status of lactating women.

Read the detailed description

This protocol was approved by the Bioethics Committee of the Department of Medicine and Health Sciences of Universidad de Sonora. A randomized controlled trial will be carried out and participant women will be assigned by simple randomization 1:1 to either the intervention or control group, upon signing an informed consent. At baseline (2wk postpartum), anthropometric (weight, height, mid upper-arm circumference and triceps skinfold thickness) and body composition (DXA) measurements as well as the assessment of vitamin A status (serum and breastmilk retinol and the modified relative dose response) will be performed. The control group will receive only recommendations for a healthy diet in accordance with international standards and will be followed up every month to promote adherence and to assess their nutritional status. On the other hand, the intervention group will receive an individualized macronutrient meal equivalent menu, with nutritional consultations every two weeks. The dietary plan will include 1-1.5 g/kg body weight protein, 30% total fat (preferably mono and polyunsaturated fatty acids), and vitamin A sources (1300 RAE). After 3 months of intervention are completed, baseline measurements will be repeated. Statistical analysis will include descriptive stats and comparisons between groups (t-tests), significance will be defined as P \< 0.05.

02

Conditions studied

  • Overweight and Obesity
  • Vitamin A Deficiency
  • Dietary Modification
  • Breastfeeding

Keywords

  • Food-based intervention
  • postpartum weight management
  • hepatic retinol
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI ≥ 25
  • Predominant breastfeeding
  • Signed Informed Consent

Exclusion criteria

Exclusion Criteria:

  • Multiparity
  • Alcohol, drugs, tobacco intake
  • Use of dietary supplements
  • Active infection (C reactive protein > 6mg/L)
  • External nutritional counseling
  • Pregnancy during the study period
  • Liver disease
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Intervention-Nutrition guidelines

    Subjects will receive an individualized dietary plan according to their nutritional status, socioeconomic and cultural preferences. Protein intake 1-1.5g/kg body weight; 30% fat (mono and polyunsaturated fatty acids), vitamin A sources (1300 RAE). Each subject will have 7 interchangeable options for every meal time, all equivalent in macronutrient content, and every two weeks a new menu will be provided by a nutritionist.

    Behavioral: Intervention-Nutrition guidelines

  • Other
    Nutrition Guidelines

    Participants will receive general nutritional recommendations according to international standards

    Behavioral: Nutrition guidelines

Interventions

  • BehavioralIntervention-Nutrition guidelines

    Subjects will receive an individualized dietary plan according to their nutritional status, socioeconomic and cultural preferences. Protein intake 1-1.5g/kg body weight; 30% fat (mono and polyunsaturated fatty acids), vitamin A sources (1300 RAE). Each subject will have 7 interchangeable options for every meal time, all equivalent in macronutrient content, and every two weeks a new menu will be provided by a nutritionist.

  • BehavioralNutrition guidelines

    Nutritional recommendations based on international guidelines

05

What researchers measure

Primary outcomes

  1. Total Body weight

    Difference in change (between baseline and final body weight within groups) between the intervention and control group, respectively

    Time frame: Baseline and 3 months after enrollment

  2. Vitamin A liver stores

    Stores are calculated as the DR/R ratio. The outcome will be calculated as the difference in change (between baseline and final VA stores within groups) between the intervention and control group, respectively

    Time frame: Baseline and 3 months after enrollment

Secondary outcomes

  1. Body fat mass

    Difference in change (between baseline and final body fat mass within groups) between the intervention and control group, respectively

    Time frame: Baseline and 3 months after enrollment

  2. Retinol

    Difference in change (between baseline and final retinol concentration within groups) between the intervention and control group, respectively

    Time frame: Baseline and 3 months after enrollment

06

Study locations

1 site
  • Universidad de Sonora
    Hermosillo, Sonora 83000, Mexico
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03640104
Lead sponsor
Universidad de Sonora
Collaborators
Centro de Investigación en Alimentación y Desarrollo A.C., University of Wisconsin, Madison
Responsible party
Verónica López Teros, PhD (Research professor, Universidad de Sonora) — Principal investigator
First posted
Aug 21, 2018
Start date
Nov 1, 2018
Primary completion
Feb 7, 2020
Completion
Feb 7, 2020
Last update
Apr 28, 2021

Study contacts

Veronica Lopez-Teros, Dr
principal investigator · Universidad de Sonora

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion